Impact of Lisinopril on Cardiometabolic Risk Factors in Men with Hypertension and Early-Onset Androgenetic Alopecia

    Robert Krysiak, Marcin Basiak, Bogusław Okopień
    Studysummary This study suggests that lisinopril's cardiometabolic effects are weaker in men with early-onset male-pattern baldness compared to those with normal hair growth.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on journals.lww.com →
    Discuss this study in the Community →

    Research cited in this study 7

    1. Polycystic Ovary Syndrome: Comprehensive Overview Obstetrics & Gynecology · 2018
    2. Gynecologic and Andrologic Dermatology and the Metabolic Syndrome Clinics in Dermatology · 2017
    3. Alopecia and the Metabolic Syndrome Clinics in Dermatology · 2017
    4. Does a Male Polycystic Ovarian Syndrome Equivalent Exist? Journal of Endocrinological Investigation · 2017
    5. Polycystic Ovary Syndrome in Men Medical Hypotheses · 2017
    6. A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women JAMA Dermatology · 2016
    7. Molecular Mechanisms of Androgenetic Alopecia Experimental Gerontology · 2002